Literature DB >> 31211106

Mitigating the adverse health effects and costs associated with smoking after a cancer diagnosis.

Graham W Warren1.   

Abstract

Smoking after a cancer diagnosis causes adverse outcomes and is associated with substantial additional treatment cost. Mitigation of the adverse effects of smoking require active commitment from health systems, providers, and patients. Three areas of mitigation are discussed: (I) smoking cessation after a cancer diagnosis to improve cancer treatment outcomes; (II) identifying optimal cancer treatment strategies for patients who smoke at the time of diagnosis; and (III) how health systems can prioritize the effect modification caused by smoking. As innovation continues for healthcare delivery, priority should be placed on interventions that reduce the effect modification and associated costs caused by continued smoking after a cancer diagnosis.

Entities:  

Keywords:  Smoking; cancer; cessation; cost; health insurance; health policy; patient centered care; tobacco; value

Year:  2019        PMID: 31211106      PMCID: PMC6546628          DOI: 10.21037/tlcr.2019.04.07

Source DB:  PubMed          Journal:  Transl Lung Cancer Res        ISSN: 2218-6751


  47 in total

1.  Methodologic barriers to addressing critical questions about tobacco and cancer prognosis.

Authors:  Stephanie R Land
Journal:  J Clin Oncol       Date:  2012-05-07       Impact factor: 44.544

2.  Prognostic value of smoking status in operated non-small cell lung cancer.

Authors:  Peyman Sardari Nia; Joost Weyler; Cecile Colpaert; Peter Vermeulen; Eric Van Marck; Paul Van Schil
Journal:  Lung Cancer       Date:  2005-03       Impact factor: 5.705

3.  A meta-analysis on salvage surgery as a potentially curative procedure in patients with isolated local recurrent or persistent esophageal cancer after chemoradiotherapy.

Authors:  Z Faiz; W P M Dijksterhuis; J G M Burgerhof; C T Muijs; V E M Mul; B P L Wijnhoven; J K Smit; J T M Plukker
Journal:  Eur J Surg Oncol       Date:  2018-11-10       Impact factor: 4.424

Review 4.  Effects of cigarette smoking on metabolism and effectiveness of systemic therapy for lung cancer.

Authors:  Meaghan O'Malley; Amanda N King; Marisa Conte; Vicki L Ellingrod; Nithya Ramnath
Journal:  J Thorac Oncol       Date:  2014-07       Impact factor: 15.609

5.  Tobacco assessment in actively accruing National Cancer Institute Cooperative Group Program Clinical Trials.

Authors:  Erica N Peters; Essie Torres; Benjamin A Toll; K Michael Cummings; Ellen R Gritz; Andrew Hyland; Roy S Herbst; James R Marshall; Graham W Warren
Journal:  J Clin Oncol       Date:  2012-06-11       Impact factor: 44.544

6.  Decreasing Smoking but Increasing Stigma? Anti-tobacco Campaigns, Public Health, and Cancer Care.

Authors:  Kristen E Riley; Michael R Ulrich; Heidi A Hamann; Jamie S Ostroff
Journal:  AMA J Ethics       Date:  2017-05-01

7.  Addressing a Core Gap in Cancer Care - The NCI Moonshot Program to Help Oncology Patients Stop Smoking.

Authors:  Robert T Croyle; Glen D Morgan; Michael C Fiore
Journal:  N Engl J Med       Date:  2019-01-02       Impact factor: 91.245

8.  Prognostic factors for limited-stage small cell lung cancer: a study of 284 patients.

Authors:  Jun Chen; Ruoxiang Jiang; Yolanda I Garces; Aminah Jatoi; Shawn M Stoddard; Zhifu Sun; Randolph S Marks; Yunpeng Liu; Ping Yang
Journal:  Lung Cancer       Date:  2009-06-03       Impact factor: 5.705

9.  Taking Stock of Tobacco Control Program and Policy Science and Impact in the United States.

Authors:  Matthew C Farrelly; Frank J Chaloupka; Carla J Berg; Sherry L Emery; Lisa Henriksen; Pamela Ling; Scott J Leischow; Douglas A Luke; Michelle C Kegler; Shu-Hong Zhu; Elizabeth M Ginexi
Journal:  J Addict Behav Ther       Date:  2017-09-15

10.  Outcomes and patterns of care of patients with locally advanced oropharyngeal carcinoma treated in the early 21st century.

Authors:  Adam S Garden; Merrill S Kies; William H Morrison; Randal S Weber; Steven J Frank; Bonnie S Glisson; Gary B Gunn; Beth M Beadle; K Kian Ang; David I Rosenthal; Erich M Sturgis
Journal:  Radiat Oncol       Date:  2013-01-29       Impact factor: 3.481

View more
  5 in total

1.  Operationalizing Leadership and Clinician Buy-In to Implement Evidence-Based Tobacco Treatment Programs in Routine Oncology Care: A Mixed-Method Study of the U.S. Cancer Center Cessation Initiative.

Authors:  Sarah D Hohl; Jennifer E Bird; Claire V T Nguyen; Heather D'Angelo; Mara Minion; Danielle Pauk; Robert T Adsit; Michael Fiore; Margaret B Nolan; Betsy Rolland
Journal:  Curr Oncol       Date:  2022-03-29       Impact factor: 3.109

2.  Increasing clinician participation in tobacco cessation by an implementation science-based tobacco cessation champion program.

Authors:  Cary A Presant; Kimlin Ashing; Sophia Yeung; Jonjon Macalintal; Brian Tiep; Argelia Sandoval; Susan Brown; Mary Cianfrocca; Loretta Erhunmwunsee; Dan Raz; Arya Amini; Ravi Salgia; Paul Fu; Amartej Merla; Heather Graves; Ranjan Pathak; Shaira Dingal; Tingting Tan; Kelley Tarkeshian; Liana Nikolaenko; Kathleen Burns; Sagus Sampath; Beverly Laksana; Brenda Gascon; Desirae Tainatongo-Landin; Veronica Degoma; Shanmuga Subbiah; Ramnik Rai; Steven Rosen
Journal:  Cancer Causes Control       Date:  2022-10-12       Impact factor: 2.532

3.  Smoking cessation and survival among people diagnosed with non-metastatic cancer.

Authors:  Tracey E Barnett; Yan Lu; Aaron W Gehr; Bassam Ghabach; Rohit P Ojha
Journal:  BMC Cancer       Date:  2020-08-05       Impact factor: 4.430

4.  PD-1/PD-L1 inhibitors as a hope for smokers of non-small cell lung cancer patient.

Authors:  Zhuo Yu; Peiqing Zhang; Weikuan Gu; Xicheng Jiang
Journal:  Transl Cancer Res       Date:  2019-12       Impact factor: 1.241

5.  Responses of smoking and nonsmoking cancer patients to drug treatment: A protocol for systematic review and meta-analysis.

Authors:  Lishi Wang; Helin Feng; Jing Li; FengXia Liu; Qingyi Liu; Jiafu Ji; Arnold Postlethwaite; Weikuan Gu; Baoen Shan
Journal:  Medicine (Baltimore)       Date:  2020-09-18       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.